Inventory

6 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves, as of June 30, 2022 and December 31, 2021 are as follows (table in thousands):

	June 30, 2022		December 31, 2021
Raw Materials	$	4,377	$	3,434
Work in Process	285		201
Finished Goods	1,990		1,964
Total	$	6,652	$	5,599

As of June 30, 2022, the Company classified $1.5 million of inventory as non-current, all of which was related to TRIFERIC® or the active pharmaceutical ingredient and raw materials for TRIFERIC®. As of June 30, 2022, the total TRIFERIC® inventory net of reserve was $1.5 million.

The $1.5 million net value of TRIFERIC® inventory consisted of $0.3 million of TRIFERIC® (dialysate) finished goods with expiration dates ranging from July 2022 to December 2023, $0.4 million of TRIFERIC® API with an estimated useful life extending through 2023, and $0.9 million of raw materials for TRIFERIC® with an estimated useful life of 25 years.